STOCK TITAN

Ecovyst Announces Agreement to Acquire Calabrian Sulfur Dioxide & Sulfur Derivatives Business

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)

Ecovyst (NYSE: ECVT) agreed to acquire Calabrian's sulfur dioxide and sulfur derivatives business from INEOS Enterprises for $190 million, subject to customary adjustments. Calabrian operates facilities in Port Neches, Texas and Timmins, Ontario. Closing is targeted by the end of Q2 2026.

Calabrian posted trailing twelve-month Adjusted EBITDA of ~$23.7 million; the purchase multiple is ~8.0x TTM Adjusted EBITDA. Ecovyst expects combined net debt leverage of ~2x at close and plans to fund the deal with cash and new debt, with synergies expected to reduce the multiple below 7.0x over three years.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Product expansion: Adds sulfur dioxide and related derivatives product lines
  • Geographic footprint: Adds manufacturing in Port Neches, TX and Timmins, ON
  • Immediate cash-flow: Calabrian TTM Adjusted EBITDA of ~$23.7M
  • Purchase economics: Transaction at ~8.0x TTM Adjusted EBITDA with expected step-down below 7.0x

Negative

  • Leverage increase: Combined net debt leverage expected to be ~2x at close
  • Closing uncertainty: Transaction subject to customary adjustments and closing conditions before end of Q2 2026

News Market Reaction – ECVT

+1.27%
1 alert
+1.27% News Effect

On the day this news was published, ECVT gained 1.27%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Purchase price: $190 million TTM Adjusted EBITDA: $23.7 million Purchase multiple: 8.0x +4 more
7 metrics
Purchase price $190 million Calabrian sulfur dioxide & sulfur derivatives business acquisition
TTM Adjusted EBITDA $23.7 million Calabrian trailing twelve-month Adjusted EBITDA
Purchase multiple 8.0x Multiple of trailing twelve-month Adjusted EBITDA at signing
Target multiple post-synergies Below 7.0x Expected purchase multiple after synergies over three years
Net debt leverage at close 2x Expected combined net debt leverage ratio at transaction close
Target closing timing End of Q2 2026 Expected closing date subject to customary conditions
Synergy realization period Three years Timeframe over which identified synergies are expected to be realized

Market Reality Check

Price: $13.81 Vol: Volume 1,171,254 is 0.59x...
low vol
$13.81 Last Close
Volume Volume 1,171,254 is 0.59x the 20-day average of 2,000,461, indicating quieter trading pre-announcement. low
Technical Shares at $14.18 are trading above the 200-day MA $10.08 and sit 1.76% below the 52-week high of $14.43.

Peers on Argus

ECVT was up 1.5% with mixed peer moves: several specialty chemicals peers (SCL, ...

ECVT was up 1.5% with mixed peer moves: several specialty chemicals peers (SCL, ODC, KRO, CLMT) were positive while MATV was slightly negative, and no peers appeared in the momentum scanner. This points to a stock-specific reaction to the acquisition rather than a broad sector rotation.

Previous Acquisition Reports

2 past events · Latest: May 06 (Positive)
Same Type Pattern 2 events
Date Event Sentiment Move Catalyst
May 06 Acquisition completion Positive +1.9% Completed Waggaman sulfuric acid asset acquisition to expand capacity and flexibility.
Mar 18 Acquisition agreement Positive +3.6% Announced agreement to acquire Waggaman sulfuric acid assets funded with cash on hand.
Pattern Detected

Past sulfur-related acquisitions have coincided with modest positive price reactions, suggesting investors have historically welcomed bolt-on deals.

Recent Company History

Over the past year, Ecovyst has repeatedly used acquisitions to build its sulfur platform. A March 18, 2025 agreement to buy Waggaman sulfuric acid assets and the completed deal on May 6, 2025 both saw positive next-day moves. Those transactions focused on expanding capacity and network flexibility in sulfuric acid. Today’s Calabrian agreement continues this strategy, extending into sulfur dioxide and sulfur derivatives and further deepening exposure to mining and water treatment end markets.

Historical Comparison

+2.8% avg move · In the last year, ECVT announced two sulfur-asset acquisitions, averaging a 2.75% next-day move. The...
acquisition
+2.8%
Average Historical Move acquisition

In the last year, ECVT announced two sulfur-asset acquisitions, averaging a 2.75% next-day move. The Calabrian deal fits this pattern of bolt-on sulfur expansion.

Ecovyst has progressed from acquiring sulfuric acid capacity at Waggaman to adding Calabrian’s sulfur dioxide and sulfur derivative products, steadily broadening its sulfur-focused platform.

Market Pulse Summary

This announcement outlines a $190 million bolt-on acquisition of Calabrian, adding sulfur dioxide an...
Analysis

This announcement outlines a $190 million bolt-on acquisition of Calabrian, adding sulfur dioxide and sulfur derivatives and deepening Ecovyst’s exposure to mining and water treatment. Management highlights Calabrian’s trailing Adjusted EBITDA of $23.7 million, an initial 8.0x multiple, and an expected net debt leverage ratio of about 2x at close. Investors may watch integration progress, synergy delivery over three years, and how this complements prior sulfur asset acquisitions.

Key Terms

adjusted ebitda, net debt leverage ratio, trailing twelve-month, purchase multiple
4 terms
adjusted ebitda financial
"Calabrian's Adjusted EBITDA profile, with trailing twelve-month Adjusted EBITDA of approximately"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
net debt leverage ratio financial
"we expect our combined net debt leverage ratio would be approximately 2x at close"
Net debt leverage ratio measures how many years of a company’s core earnings would be needed to pay off its debt after accounting for cash on hand, calculated by dividing net debt (total debt minus cash) by annual operating earnings. Investors use it like a household debt-to-income check: a lower number means the company is in a stronger position to handle obligations and take risks, while a higher number signals greater financial strain and vulnerability to shocks.
trailing twelve-month financial
"trailing twelve-month Adjusted EBITDA of approximately $23.7 million"
Trailing twelve-month (TTM) is a measurement that adds up a company’s financial results from the most recent 12 months to show its current performance, rather than using a fixed fiscal year. Think of it like looking at a moving one‑year snapshot to smooth out seasonal swings and short‑term bumps; investors use TTM figures for revenue, earnings, and ratios to get a more up‑to‑date view when comparing companies or valuing a stock.
purchase multiple financial
"The transaction reflects a purchase multiple of approximately 8.0x trailing twelve-month"
A purchase multiple is a simple ratio that shows how much is being paid for a company compared with a measure of its earnings or cash flow — for example, the purchase price divided by annual profit. It helps investors judge whether an acquisition or takeover price is high or low, like comparing the sale price of a rental property to its annual rent; higher multiples mean buyers are paying more for each dollar of income and may face lower future returns if growth or cost savings don’t materialize.

AI-generated analysis. Not financial advice.

WAYNE, Pa., May 1, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services ("Ecovyst"), announced today that it has signed a definitive agreement to acquire the Calabrian sulfur dioxide and related sulfur derivatives business ("Calabrian") from INEOS Enterprises for a purchase price of $190 million, subject to certain customary adjustments. Through its manufacturing facilities in Port Neches, Texas and Timmins, Ontario, Canada, Calabrian is a leading producer of sulfur dioxide and related sulfur derivatives in North America, serving key end uses including mining, water treatment and specialty chemical production. Following closing, the acquisition is expected to expand Ecovyst's existing product and service offering through further expansion into the sulfur dioxide, sodium bisulfite, sodium thiosulfate and sodium metabisulfite product groups. The transaction is targeted to close by the end of second quarter of 2026, subject to satisfaction of customary closing conditions. 

"The Calabrian acquisition aligns with our strategy to deliver shareholder value by leveraging our sulfur chemistry expertise, while also diversifying our portfolio and further expanding our presence in key end use segments such as mining," said Kurt J. Bitting, Ecovyst's Chief Executive Officer. "Ecovyst is already an established producer of sodium bisulfite, and Calabrian's sulfur dioxide and other sulfur derivative product offerings share meaningful end-use, customer, and sulfur-chemistry overlap with Ecovyst, positioning us to integrate Calabrian's product portfolio onto a familiar commercial and operational footprint. Similar to our existing businesses, Calabrian has a highly experienced and engaged management team, and a diverse base of long-standing, blue-chip customers, with a high degree of recurring sales under significant long-term contracts. In addition, the Calabrian business is characterized by strong cash generation and Adjusted EBITDA margins that are expected to be accretive to Ecovyst's portfolio," Bitting added.  

Ashley Reed, Chairman of INEOS Enterprises said, "INEOS Calabrian has been part of INEOS Enterprises for the past ten years, during which time it has delivered significant improvements in safety, operational performance and financial results. This transaction, valued at $190 million, subject to certain customary adjustments, reflects our disciplined approach to portfolio management — acquiring businesses, improving them at pace, and realizing value.

Calabrian is a strong, well-positioned semi-specialty chemicals business. However, it is not a core fit within INEOS's long-term portfolio. Ecovyst is well placed to take the business forward and support its next phase of growth".

"Consistent with our disciplined capital allocation strategy, we intend to fund the Calabrian acquisition through a combination of cash on hand and proceeds of new debt financing," said Mike Feehan, Ecovyst's Chief Financial Officer. "Given Calabrian's Adjusted EBITDA profile, with trailing twelve-month Adjusted EBITDA of approximately $23.7 million, we expect our combined net debt leverage ratio would be approximately 2x at close of the transaction. The transaction reflects a purchase multiple of approximately 8.0x trailing twelve-month Adjusted EBITDA, which we expect to step down to below 7.0x as identified synergies are fully realized over the three years following close," said Feehan.

Lazard Frères & Co. LLC is serving as financial advisor, and Ropes & Gray LLP and Babst, Calland, Clements and Zomnir, P.C. are serving as legal counsel to Ecovyst. 

About Ecovyst

Ecovyst Inc. and subsidiaries is a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services. We believe that our products and services contribute to improving the sustainability of the environment.

We are a leading provider of sulfuric acid recycling to the North American refining industry for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are also a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. We also provide chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry.

For more information, see our website at https://www.ecovyst.com.

About Ineos Calabrian

INEOS Calabrian is a leading on purpose manufacturer of ultra-pure sulfur dioxide and related derivatives such as sodium bisulfite, sodium metabisulfite, sodium thiosulfate and sodium sulfite.  The company operates integrated manufacturing facilities in Port Neches, TX, USA and Timmins, ON, Canada. SO2 produced by INEOS Calabrian derivatives – sodium bisulfite, sodium thiosulfate and sodium metabisulfite – exceed quality standards across a range of industries.

Presentation of Non-GAAP Financial Measures

This press release includes certain non-GAAP financial measures, including Adjusted EBITDA and combined net debt leverage ratio, which are provided to assist in an understanding of our business and its performance. These non-GAAP financial measures should be considered only as supplemental to, and not as superior to, financial measures prepared in accordance with GAAP. Non-GAAP financial measures should be read only in conjunction with consolidated financials prepared in accordance with GAAP. In reliance upon the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K, the Company is not able to provide a reconciliation of non-GAAP financial projections to the corresponding GAAP measures without unreasonable effort because of the inherent difficulty in forecasting and quantifying certain amounts necessary for such a reconciliation such as certain non-cash, nonrecurring or other items that are included in net (loss) income and EBITDA as well as the related tax impacts of these items and asset dispositions / acquisitions and changes in foreign currency exchange rates that are included in cash flow, due to the uncertainty and variability of the nature and amount of these future charges and costs. Because this information is uncertain, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

Note on Forward-Looking Statements

Some of the information contained in this press release constitutes "forward-looking statements." Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "projects," "aims" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, the anticipated benefits and timing of the closing of the transaction, expected purchase price, and our anticipated financial position following consummation of the transaction, including our combined net debt leverage ratio, the ability to satisfy or waive the conditions to closing and the ability to complete the transaction considering the various closing conditions. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the possibility that the conditions to the closing of the transaction are not satisfied; the occurrence of any event, change or other circumstance that could give rise to a right to terminate the transaction; unexpected costs, liabilities or delays in connection with the transaction; legal proceedings initiated in connection with the transaction; risks related to the integration of the acquired business; regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes; currency exchange rates; the effects of inflation; and other factors, including those described in the sections titled "Risk Factors" and "Management's Discussion & Analysis of Financial Condition and Results of Operations" in our filings with the SEC, which are available on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

For more information:
Gene Shiels – Director of Investor Relations
(484) 617 1225
gene.shiels@ecovyst.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ecovyst-announces-agreement-to-acquire-calabrian-sulfur-dioxide--sulfur-derivatives-business-302760083.html

SOURCE Ecovyst Inc.

FAQ

What is Ecovyst (ECVT) paying for Calabrian's sulfur dioxide business and when will the deal close?

Ecovyst is acquiring the business for $190 million, subject to customary adjustments. According to the company, the transaction is targeted to close by the end of Q2 2026, subject to satisfaction of closing conditions.

How will the Calabrian acquisition affect Ecovyst's product offerings (ECVT)?

The acquisition expands Ecovyst into sulfur dioxide and related derivatives including sodium bisulfite and sodium metabisulfite. According to the company, this broadens Ecovyst's sulfur-chemistry portfolio and end-use exposure in mining, water treatment, and specialty chemicals.

What are the financial metrics of the Calabrian deal for Ecovyst (ECVT)?

Calabrian reported trailing twelve-month Adjusted EBITDA of ~$23.7M and the purchase multiple is ~8.0x. According to the company, synergies are expected to lower the multiple to below 7.0x within three years.

How will Ecovyst finance the $190 million Calabrian acquisition (ECVT)?

Ecovyst intends to fund the acquisition with a combination of cash on hand and new debt financing. According to the company, combined net debt leverage is expected to be approximately 2x at closing.

Does Calabrian operate manufacturing sites that Ecovyst will acquire (ECVT)?

Yes. Calabrian operates manufacturing facilities in Port Neches, Texas and Timmins, Ontario. According to the company, these sites produce sulfur dioxide and related sulfur derivatives serving mining, water treatment, and specialty chemical customers.